Person

Ronald E. Blaylock

Director, Pfizer

Current S&P 500 boards
2
Current roles
2
Open-market buys
$2.0M
Open-market sales
$0

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

None on record since 2016.

Sits alongside

People who currently share a board or management team with this person.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Aug 5, 2026PFEBuy39,231$25.46$999K
Feb 13, 2025PFEBuy19,457$25.65$499K
Aug 6, 2020PFEBuy1,000$38.62$39K
Aug 6, 2020PFEBuy1,000$38.69$39K
Aug 6, 2020PFEBuy1,500$38.51$58K
Aug 6, 2020PFEBuy3,000$38.55$116K
Aug 6, 2020PFEBuy4,000$38.49$154K
Aug 6, 2020PFEBuy2,500$38.56$96K

SEC reporting-owner ID (CIK) 1214686 · all filings on EDGAR